CASTLE BIOSCIENCES INC Quarterly Cost of Revenue in USD from Q2 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Castle Biosciences Inc quarterly/annual Cost of Revenue history and growth rate from Q2 2020 to Q3 2024.
  • Castle Biosciences Inc Cost of Revenue for the quarter ending September 30, 2024 was $15.6M, a 37.9% increase year-over-year.
  • Castle Biosciences Inc Cost of Revenue for the twelve months ending September 30, 2024 was $56.4M, a 34.1% increase year-over-year.
  • Castle Biosciences Inc annual Cost of Revenue for 2023 was $45M, a 40.5% increase from 2022.
  • Castle Biosciences Inc annual Cost of Revenue for 2022 was $32M, a 102% increase from 2021.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $56.4M $15.6M +$4.29M +37.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 $52.2M $14.5M +$3.46M +31.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $48.7M $13.9M +$3.71M +36.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $45M $12.4M +$2.9M +30.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $42.1M $11.3M +$2.46M +27.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 $39.6M $11.1M +$3.37M +43.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
Q1 2023 $36.2M $10.2M +$4.24M +71.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $32M $9.52M +$4.92M +107% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $27.1M $8.86M +$4.36M +96.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $22.7M $7.69M +$3.99M +108% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $18.7M $5.94M +$2.92M +96.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $15.8M $4.6M Oct 1, 2021 Dec 31, 2021 10-K 2023-02-28
Q3 2021 $4.5M +$2.03M +81.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $3.7M +$1.55M +72.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $3.03M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q3 2020 $2.48M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $2.15M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.